|Agreement labeling||Elsevier Read and Publish Agreement 2022-2024|
|Has the agreement been fully disclosed and published?||Yes|
|Agreement period||01/01/2022 – 12/31/2024|
|Consortia / Institution||Jisc|
Approximate range of annual corresponding author publications
|Comments on size/article output||Unlimited article output but the above number is predicted 2022 UK publishing output|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Comments on cost development||15% reduction on an institution’s 2021 contracted spend|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|Unlimited OA publishing|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Fully OA titles are included selectively|
|OA LICENSE||CC-BY mandatory|
||Original research articles
Case Reports / Data in Brief / Microarticle / Original Software Publication / Protocol / Replication Study / Short Communication / Short Survey / Video Article / Practice Guideline
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
|Comments on access costs||Breakdown of access and publishing costs not specified|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|OVERALL ASSESSMENT AND COMMENTS||This agreement will have a huge impact on the overall UK open access transition as it will include unlimited OA publishing in Core hybrid, Cell Press and The Lancet titles. Read access remains the same as previous 2021 subscription titles. Publishing in fully OA titles is an optional extra with 15% discount off the standard APC. Read and Publish Pricing is based on an institution’s 2021 contracted subscription spend inside and outside Jisc with a 15% reduction.|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|